Skip to Content

Unigene Laboratories Inc UGNEQ

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

UGNEQ is trading at a 347% premium.
Price
$0.00
Fair Value
$6.88
Uncertainty
Extreme
1-Star Price
$3.62
5-Star Price
$9.59
Economic Moat
Zjrbfb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if UGNEQ is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Unigene Laboratories Inc is engaged in the research, production, and drug delivery of peptides for therapeutic use in the United States.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
53

Valuation

Metric
UGNEQ
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
UGNEQ
Quick Ratio
0.00
Current Ratio
0.02
Interest Coverage
−0.96
Quick Ratio
No chart available

Profitability

Metric
UGNEQ
Return on Assets (Normalized)
−141.42%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
TlltqzfkGbhn$636.2 Bil
Vertex Pharmaceuticals Inc
VRTX
RxqhjczsCqczqb$126.1 Bil
Regeneron Pharmaceuticals Inc
REGN
PgcdgkhxzZcrskt$121.2 Bil
Moderna Inc
MRNA
BfftxpwwYvlc$46.5 Bil
Alnylam Pharmaceuticals Inc
ALNY
QlvgxfmvJzrvyl$33.0 Bil
argenx SE ADR
ARGX
FkxlzcvpPxd$27.9 Bil
BioNTech SE ADR
BNTX
WcjlvsdcZhld$20.5 Bil
Biomarin Pharmaceutical Inc
BMRN
WxgxpxlknRszdss$16.1 Bil
United Therapeutics Corp
UTHR
LyhknvyHswj$14.3 Bil
Incyte Corp
INCY
GpdvxdzgJwfmby$12.5 Bil

Sponsor Center